Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.

PURPOSE Many patients with localized node-negative renal cell carcinoma (RCC) are elderly with competing comorbidities. Their overall survival benefit after surgical treatment is unknown. We reviewed cases in the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the impact of kidney cancer versus competing causes of death in patients with localized RCC and develop a compre...

effective factors for risk of death in patients with cirrhosis using competing risks model

background: including multivariate survival data can be pointed competing risks data. there are various methods to analyze such data such as semi-parametric methods of cause-specific hazard function, and cumulative incidence function. the aim of this study was to deploy competing risks model to analyze the determinants of patients with liver cirrhosis. materials and methods: during the one-year...

Parametric Estimation in a Recurrent Competing Risks Model

A resource-efficient approach to making inferences about the distributional properties of the failure times in a competing risks setting is presented. Efficiency is gained by observing recurrences of the compet- ing risks over a random monitoring period. The resulting model is called the recurrent competing risks model (RCRM) and is coupled with two repair strategies whenever the system fails. ...

Predicting Factors for Death from Other Causes in Patients with Localized Renal Cell Carcinoma

PURPOSE To identify the predictors of death from other causes in patients with localized renal cell carcinoma (RCC). MATERIALS AND METHODS We identified 1,101 patients with pathologically confirmed T1 or T2 RCC with a follow-up duration of over 6 months. Survival according to the cause of death was evaluated by using the Kaplan-Meier analysis with log-rank test. Prognostic factors for death f...

Competing risks for patients with localized prostate cancer.